Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H29NO3 |
InChIKeyMGHIXPKFVULGHX-FQEVSTJZSA-N |
CAS Registry1173289-66-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 23 Jul 2009 |